 |
|
Aspirin recommendation underscores need for physicians and patients to discuss benefits and risk
March 18, 2009American College of Preventive Medicine applauds task force for improving guidelines
Washington, DC - The President of the American College of Preventive Medicine commended the U.S. Preventive Services Task Force (USPSTF) today for its recommendations on aspirin use for primary prevention of heart attack and stroke, released in the March 17 issue of the Annals of Internal Medicine, citing its improved specificity over previous guidelines.
The task force recommends aspirin use for prevention of cardiovascular disease when the benefits clearly outweigh the risks or harms. The task force found that men between the ages of 45 and 79 should use aspirin to reduce their risk for heart attacks when the benefits outweigh the harms for potential gastrointestinal bleeding; and that women between the ages of 55 and 79 should use aspirin to reduce their risk for ischemic stroke when the benefits outweigh the harms for potential gastrointestinal bleeding. The task force also recommended against the use of aspirin for stroke prevention in women younger than 55 years and for myocardial infarction prevention in men younger than 45 years.
"The task force has taken positive steps to lend clarity to patients and physicians about the value of aspirin for prevention of cardiovascular events," says ACPM President Mark B. Johnson, MD, MPH, FACPM. "The new guidelines make it clear that physicians, as a matter of routine practice, should be discussing the pros and cons of daily aspirin use with patients in the target groups."
An ACPM-sponsored survey published in the May 2007 edition of the American Journal of Preventive Medicine found a conversation between the patient and physician to be the strongest predictor of appropriate aspirin use, and that only about one in three patients who are at high risk are actually taking daily aspirin. A separate study by the Partnership for Prevention found that 45,000 lives could be saved each year if 90% of the target population took a low-dose aspirin every day. These studies led the American Medical Association to adopt a policy to increase education among physicians on the importance of appropriate aspirin counseling.
With today's release, the USPSTF updates its aspirin recommendations from 2002, which called on clinicians to discuss aspirin use for primary prevention with adults who are at increased risk for cardiovascular disease. The new USPSTF findings actually recommend aspirin use where benefits outweigh the harms, and further define the appropriate age and gender groupings for which aspirin is indicated.
"We think the new guidelines provide another tool in the armamentarium of the physician and the patient for assuring that a discussion about cardiovascular risk and potential aspirin use routinely takes place in the clinical setting," says David Shih, MD, MS, ACPM senior director of medical affairs. ACPM is leading the development of the national initiative, "Aspirin Talks: Start a Life-Saving Conversation," whose goal is to improve appropriate aspirin use to prevent heart attacks and strokes. Under the initiative ACPM is developing and testing an office-level intervention designed to help clinicians engage in a conversation about aspirin, featuring a tool kit with physician, patient, and clinic aids to facilitate aspirin therapy counseling.
American College of Preventive Medicine
"The task force has taken positive steps to lend clarity to patients and physicians about the value of aspirin for prevention of cardiovascular events," says ACPM President Mark B. Johnson, MD, MPH, FACPM. "The new guidelines make it clear that physicians, as a matter of routine practice, should be discussing the pros and cons of daily aspirin use with patients in the target groups."
An ACPM-sponsored survey published in the May 2007 edition of the American Journal of Preventive Medicine found a conversation between the patient and physician to be the strongest predictor of appropriate aspirin use, and that only about one in three patients who are at high risk are actually taking daily aspirin. A separate study by the Partnership for Prevention found that 45,000 lives could be saved each year if 90% of the target population took a low-dose aspirin every day. These studies led the American Medical Association to adopt a policy to increase education among physicians on the importance of appropriate aspirin counseling.
With today's release, the USPSTF updates its aspirin recommendations from 2002, which called on clinicians to discuss aspirin use for primary prevention with adults who are at increased risk for cardiovascular disease. The new USPSTF findings actually recommend aspirin use where benefits outweigh the harms, and further define the appropriate age and gender groupings for which aspirin is indicated.
"We think the new guidelines provide another tool in the armamentarium of the physician and the patient for assuring that a discussion about cardiovascular risk and potential aspirin use routinely takes place in the clinical setting," says David Shih, MD, MS, ACPM senior director of medical affairs. ACPM is leading the development of the national initiative, "Aspirin Talks: Start a Life-Saving Conversation," whose goal is to improve appropriate aspirin use to prevent heart attacks and strokes. Under the initiative ACPM is developing and testing an office-level intervention designed to help clinicians engage in a conversation about aspirin, featuring a tool kit with physician, patient, and clinic aids to facilitate aspirin therapy counseling.
American College of Preventive Medicine
Aspirin Current Events and Aspirin News RSSCommon Pain Relievers May Dilute Power of Flu Shots
With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers - Advil, Tylenol, aspirin - at the time of injection may blunt the effect of the shot and have a negative effect on the immune system.
News brief: Effects of aspirin and folic acid on inflammation markers for colorectal adenomas
Unexpectedly, inflammation markers do not appear to be involved with the chemopreventative effect of aspirin on colorectal adenomas, according to a brief communication published online October 12 in the Journal of the National Cancer Institute.
Aspirin Misuse May Have Made 1918 Flu Pandemic Worse
The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin.
Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine
Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines such as omeprazole, known as proton pump inhibitors (PPIs), did not lead to adverse events, as some prior studies had suggested.
Aspirin works for primary prevention in moderate and high risk diabetics
The beneficial effects of aspirin in primary prevention of cardiovascular events i.e. stroke, MI and cardiac death are known and generally accepted.
New strategies for reperfusion therapy
A new trial has begun in order to ascertain once and for all whether the best strategy for patients who cannot receive P-PCI is early fibrinolysis, together with mandated angiography.
Small peptide found to stop lung cancer tumor growth in mice
In new animal research done by investigators at Wake Forest University School of Medicine, scientists have discovered a treatment effective in mice at blocking the growth and shrinking the size of lung cancer tumors, one of the leading causes of cancer death in the world.
Genetic variation associated with poorer response, cardiovascular outcomes with use of clopidogrel
Patients with a certain genetic variation who received the antiplatelet drug clopidogrel had a decreased platelet response to treatment and among those who had percutaneous coronary intervention (procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) had an increased risk of having a cardiovascular event in the following year than patients who did not have this variant, according to a study in the August 26 issue of JAMA.
Study reveals mounting evidence of fish oil's heart health benefits
There is mounting evidence that omega-3 fatty acids from fish or fish oil supplements not only help prevent cardiovascular diseases in healthy individuals, but also reduce the incidence of cardiac events and mortality in patients with existing heart disease.
Link between migraines and reduced breast cancer risk confirmed in follow-up study
The relationship between migraine headaches in women and a significant reduction in breast cancer risk has been confirmed in a follow-on study to landmark research published last year and conducted by scientists at Fred Hutchinson Cancer Research Center.
More Aspirin Current Events and Aspirin News Articles
![Bayer Low Dose Aspirin Regimen - 400 Tablets [Health and Beauty]](http://ecx.images-amazon.com/images/I/51SE%2BuzGlJL._SL160_.jpg) |
Bayer Low Dose Aspirin Regimen - 400 Tablets [Health and Beauty] by Bayer Safety Coated "Baby" Aspirin - Aspirin Regimen For Adult Use * Often Recommended as "Baby" Aspirin by Doctors for Adult Aspirin Regimen Use * Small, Easy-To-Swallow Tablets * Safety Coated for Added Stomach Protection * Aspiring Protects Your Heart by Keeping Your Blood Flowing Freely For the temporary relief of minor aches and pains or as recommended by your doctor. Because of its delayed action, this product will not provide fast relief of headaches or other symptoms needing immediate relief. Ask your doctor about other uses for Safety Coated 81 mg Aspirin. |
 |
Member's Mark - Aspirin 81 mg, Adult Low Strength, 500 Tablets, Compare to St. Joseph's by Sam's West, Inc. 500 tablets |
 |
Low Dose Aspirin (enteric coated) 81mg 500 Tablets by Life Extension Numerous studies document the multiple health benefits of daily low dose aspirin. Aspirin helps to maintain normal platelet aggregation in blood vessels and the production of prostaglandin E2 and possibly C-reactive protein. |
 |
Equate - Aspirin 325 mg, Original Strength, 500 Coated Tablets, Pain Reliever (Compare to Buyer) by Perrigo. |
 |
KS Enteric Coated Aspirin 81 mg Tablets - Adult Low Strength Regimen - Compare to the Active Ingredients in Bayer Enteric Coated Low Strength Aspirin - 730 ct. by Kirkland Signature Read all instructions and warnings before taking this or any other medication. |
 |
Bayer Aspirin Pain Reliever/ Fever Reducer, 300-Count Coated Tablets (Pack of 2) by Bayer Pain Reliever/Fever Reducer. Fast, safe pain relief Plus the life saving benefits of aspirin. Headaches; Everyday aches and pains. Doctor recommended for Aspirin Regimen Use. Aspirin is not appropriate for everyone, so be sure to talk to your doctor befor |
 |
Bayer Aspirin Pain Reliever/ Fever Reducer, Low Dose Safety Coated for Baby (81 mg), 200-Count Enteric Coated Tablets (Pack of 2) by Bayer It is most often used by patients who are taking aspirin on a regular basis under a doctor's supervision. This product contains one-quarter the medicine of a regular strength aspirin tablet allowing you to more conveniently take the dosage directed by you |
 |
Bayer Aspirin Pain Reliever/ Fever Reducer, Extra Strength PLUS, 50-Count Caplets (Pack of 4) by Bayer Aspirin PLUS a "Buffer" to guard against upset stomach, Use for the temporary relief of headache, muscle pain, toothache, pain and fever of colds, menstrual pain, minor pain of arthritis |
 |
Bayer Genuine Aspirin 325mg 500 tablets by Bayer THE WONDER DRUG Fast, Safe Pain Relief Plus The Life Saving Benefits of Aspirin Uses temporarily relieves headache menstrual pain muscle pain pain and fever of colds toothache minor pain of arthritis Directions: Active Ingredients (in each tablet): Inactive Ingredients: *May contain this ingredient. Warnings: |
 |
BOTTLED ASPIRIN 1000/BOTTLE by GERI-CARE PHARMACEUTICALS 5 grain USP aspirin. Low cost generic bottled pain relief. 1000 tablets per bottle. |
| © 2009 BrightSurf.com |